Skip to content
10-Q

Quarterly Report

MELINTA THERAPEUTICS, INC. /NEW/

0001461993-19-000059

← back to feed
Filed
Nov 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 6, 2019 13.75M sh
Capex Q3 2019 · Sep 30, 2019 $12K
Capex Q3 2019 · Sep 30, 2018 $1.44M
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$89.82M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$170.71M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $63.52M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $81.81M
Stockholders Equity Q3 2019 · Sep 30, 2019 −$60.53M
Stockholders Equity Q3 2019 · Jun 30, 2019 $141.67M
Stockholders Equity Q3 2019 · Mar 31, 2019 $176.52M
Stockholders Equity Q3 2019 · Dec 31, 2018 $190.06M
Stockholders Equity Q3 2019 · Sep 30, 2018 $234.78M
Stockholders Equity Q3 2019 · Jun 30, 2018 $260.97M
Stockholders Equity Q3 2019 · Mar 31, 2018 $199.83M
Stockholders Equity Q3 2019 · Dec 31, 2017 $72.34M
Current Liabilities Q3 2019 · Sep 30, 2019 $128.05M
Current Liabilities Q3 2019 · Dec 31, 2018 $133.61M
Total Liabilities Q3 2019 · Sep 30, 2019 $289.02M
Total Liabilities Q3 2019 · Dec 31, 2018 $251.53M
Current Assets Q3 2019 · Sep 30, 2019 $131.27M
Current Assets Q3 2019 · Dec 31, 2018 $149.48M
Total Assets Q3 2019 · Sep 30, 2019 $228.49M
Total Assets Q3 2019 · Dec 31, 2018 $441.59M
Sga Expense Q3 2019 · Sep 30, 2019 $26.42M
Sga Expense Q3 2019 · Sep 30, 2019 $83.29M
Sga Expense Q3 2019 · Sep 30, 2018 $34.29M
Sga Expense Q3 2019 · Sep 30, 2018 $103.86M
Rd Expense Q3 2019 · Sep 30, 2019 $4.7M
Rd Expense Q3 2019 · Sep 30, 2019 $13.59M
Rd Expense Q3 2019 · Sep 30, 2018 $13.07M
Rd Expense Q3 2019 · Sep 30, 2018 $45.01M
Net Income Q3 2019 · Sep 30, 2019 −$213.38M
Net Income Q3 2019 · Sep 30, 2019 −$276.09M
Net Income Q3 2019 · Jun 30, 2019 −$36.18M
Net Income Q3 2019 · Mar 31, 2019 −$26.53M
Net Income Q3 2019 · Sep 30, 2018 −$27.86M
Net Income Q3 2019 · Sep 30, 2018 −$113.07M
Net Income Q3 2019 · Jun 30, 2018 −$55.78M
Net Income Q3 2019 · Mar 31, 2018 −$29.43M
Operating Income Q3 2019 · Sep 30, 2019 −$200.18M
Operating Income Q3 2019 · Sep 30, 2019 −$251.91M
Operating Income Q3 2019 · Sep 30, 2018 −$26.67M
Operating Income Q3 2019 · Sep 30, 2018 −$119.99M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $8.21M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $24.22M
Cost Of Revenue Q3 2019 · Sep 30, 2018 $13.39M
Cost Of Revenue Q3 2019 · Sep 30, 2018 $32.07M
Revenue Q3 2019 · Sep 30, 2019 $15.87M
Revenue Q3 2019 · Sep 30, 2019 $45.91M
Revenue Q3 2019 · Sep 30, 2018 $34.08M
Revenue Q3 2019 · Sep 30, 2018 $60.94M